Dr. Anne Hudson Blaes, MD

Dr. Blaes practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Blaes' NPI, 1285690156, was assigned on April 21, 2006. Dr. Blaes graduated from Loyola University Chicago Stritch School of Medicine in 2002. Dr. Blaes holds Minnesota license 46333.

Dr. Blaes' primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Blaes' primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Blaes is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Blaes to 3 more hospitals, 4 group practices and clinics, 4 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blaes practices, 10 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Blaes' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Blaes is board certified in internal medicine by the American Board of Internal Medicine. Dr. Blaes is licensed in Minnesota.

Dmand AI lists breast cancer, colorectal cancer, lung cancer and prostate cancer among the conditions Dr. Blaes treats.

CMS data shows 69 Medicare services from Dr. Blaes across 3 procedure codes in 2024, all of them office visits, for 62 Medicare patients. Medicare paid $5,229 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 62 Medicare patients who saw Dr. Blaes in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have cancer, and 56% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blaes' median patient age at 58, with 94% women.

In 2024, Dr. Blaes wrote 356 Medicare Part D claims for 81 patients. 85% of them were for generic drugs. CMS names the drug for 214 of them, across 7 drugs with 11 or more claims each, at $277,235 in total drug cost. In 2023, CMS named 212 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Blaes for performance year 2024, reported as part of a group. Dr. Blaes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blaes as offering telehealth.

Dmand AI links 162 papers to Dr. Blaes, published from 2010 to 2025. 2024 was the busiest year, with 18. The most frequent topics are Breast Neoplasms, Cancer Survivors and Cardiovascular Diseases. Dr. Blaes has published most often in J Cancer Surviv. Dr. Blaes' most frequent co-authors are Arjun Gupta, MBBS, Heather Christine Beckwith, MD and Jane Yuet Ching Hui, MD.

Dmand AI links Dr. Blaes to 5 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Lymphatic Diseases. Masonic Cancer Center, University of Minnesota sponsors the most, 3.

CMS Open Payments shows 10 general payments to Dr. Blaes from 8 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $243.

Dmand AI lists 1 award for Dr. Blaes, most recently CMS Stage 1 EHR in 2013.

Dr. Blaes graduated from Loyola University Chicago Stritch School of Medicine in 2002. Dr. Blaes is a member of ASCO.

Dr. Blaes is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.